CELU Stock Summary and Trading Ideas (Celularity - Class A | NASDAQ:CELU)

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Celularity - Class A trades on the NASDAQ stock market under the symbol CELU.

As of October 1, 2026, CELU stock price climbed to $1.37 with 12,991 million shares trading.

CELU has a beta of 1.50, meaning it tends to be more sensitive to market movements. CELU has a correlation of 0.03 to the broad based SPY ETF.

CELU has a market cap of $44.46 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CELU traded as high as $7.97 and as low as $.56.

The top ETF exchange traded funds that CELU belongs to (by Net Assets): VTI, VXF.

CELU has underperformed the market in the last year with a return of -33.8%, while SPY returned +15.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CELU shares. However, CELU has outperformed the market in the last 3 month and 2 week periods, returning +129.1% and +6.2%, while SPY returned +2.0% and +1.0%, respectively. This indicates CELU has been having a stronger performance recently.

CELU support price is $1.26 and resistance is $1.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELU shares will trade within this expected range on the day.